Martí-Díaz, R.; Montenegro, M.F.; Cabezas-Herrera, J.; Goding, C.R.; Rodríguez-López, J.N.; Sánchez-del-Campo, L.
Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions. Cancers 2021, 13, 102.
https://doi.org/10.3390/cancers13010102
AMA Style
Martí-Díaz R, Montenegro MF, Cabezas-Herrera J, Goding CR, Rodríguez-López JN, Sánchez-del-Campo L.
Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions. Cancers. 2021; 13(1):102.
https://doi.org/10.3390/cancers13010102
Chicago/Turabian Style
Martí-Díaz, Román, María F. Montenegro, Juan Cabezas-Herrera, Colin R. Goding, José Neptuno Rodríguez-López, and Luis Sánchez-del-Campo.
2021. "Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions" Cancers 13, no. 1: 102.
https://doi.org/10.3390/cancers13010102
APA Style
Martí-Díaz, R., Montenegro, M. F., Cabezas-Herrera, J., Goding, C. R., Rodríguez-López, J. N., & Sánchez-del-Campo, L.
(2021). Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions. Cancers, 13(1), 102.
https://doi.org/10.3390/cancers13010102
